Legal & General Group PLC Amgen Inc Transaction History

Legal & General Group PLC

$420 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Amgen Inc stock. As of the latest transaction made, Legal & General Group PLC holds 4,943,574 shares of AMGN stock, worth $1.51 Billion. This represents 0.33% of its overall portfolio holdings.

Number of Shares

4,943,574

Previous 5,024,173 1.6%

Holding current value

$1.51 Billion

Previous $1.45 Billion 2.87%

% of portfolio

0.33%

Previous 0.38%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $21.7 Million - $26.2 Million	-80,599 Reduced 1.6%	4,943,574 $1.41 Billion
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $246 Million - $278 Million	963,555 Added 23.73%	5,024,173 $1.45 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $33.4 Million - $41.5 Million	-152,947 Reduced 3.63%	4,060,618 $1.09 Billion
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $27.8 Million - $32.9 Million	129,681 Added 3.18%	4,213,565 $935 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $3.86 Million - $4.71 Million	17,109 Added 0.42%	4,083,884 $987 Million

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $43.2 Million - $54.9 Million	-188,750 Reduced 4.44%	4,066,775 $1.07 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $38.3 Million - $43.2 Million	-170,586 Reduced 3.85%	4,255,525 $959 Million
Q2 2022 Aug 22, 2022	SELL	$230.71 - $256.74 $23.7 Million - $26.4 Million	-102,706 Reduced 2.27%	4,426,111 $1.08 Billion
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $54.3 Million - $60.1 Million	247,748 Added 5.79%	4,528,817 $1.1 Billion
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $16.6 Million - $19 Million	-83,395 Reduced 1.91%	4,281,069 $963 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $31.1 Million - $36.5 Million	146,679 Added 3.48%	4,364,464 $928 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $57.1 Million - $63.4 Million	244,578 Added 6.16%	4,217,785 $1.03 Billion
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $16.7 Million - $19.5 Million	-75,289 Reduced 1.86%	3,973,207 $989 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $10.7 Million - $12.8 Million	49,631 Added 1.24%	4,048,496 $931 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $5.67 Million - $6.3 Million	-24,154 Reduced 0.6%	3,998,865 $1.02 Billion
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $30.5 Million - $37.4 Million	154,051 Added 3.98%	4,023,019 $949 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $7.51 Million - $9.96 Million	41,227 Added 1.08%	3,868,968 $785 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $500,649 - $643,507	-2,646 Reduced 0.07%	3,827,741 $923 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $1.52 Million - $1.82 Million	-8,723 Reduced 0.23%	3,830,387 $741 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $20.6 Million - $24.1 Million	-123,279 Reduced 3.11%	3,839,110 $707 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $130 Million - $147 Million	720,809 Added 22.24%	3,962,389 $753 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $31.1 Million - $36.3 Million	174,360 Added 5.68%	3,241,580 $631 Million
Q3 2018 Nov 20, 2018	SELL	$185.29 - $208.89 $2.3 Million - $2.6 Million	-12,434 Reduced 0.4%	3,067,220 $636 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $58.5 Million - $65.7 Million	-352,230 Reduced 10.26%	3,079,654 $568 Million
Q1 2018 May 17, 2018	SELL	$169.43 - $198.0 $45.9 Million - $53.7 Million	-271,116 Reduced 7.32%	3,431,884 $585 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $625 Million - $698 Million	3,703,000	3,703,000 $644 Million

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Amgen Inc Transaction History